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Herpes simplex virus type 1 (HSV-1) is a highly 
prevalent pathogen among children and adults, 
causing primary infections that are presented clini-
cally as herpes labialis or as primary gingivosto-
matitis. The virus is also able to establish a latent 
infection in the nervous system that can be fre-
quently reactivated [1]. Major therapeutic agents 
for HSV infections are nucleoside analogues such 
as acyclovir and vidarabine. However, the in-
creased and prolonged use of these compounds, 
in particular in immunocompromised patients, 
has led to viral resistance against most of these 
drugs [2, 3]. The drug-resistant HSV retain their 
pathogenicity and may be associated with progres-
sive and relapsing disease. Thus, it is necessary to 
explore and discover novel potential antiherpetic 
approaches.
Many edible mushrooms were described in the 
traditional folklore of the Asian culture as me-
dicinal remedies towards a variety of disorders 
and diseases. Recent studies, with a better scien-
tific background, confirm the presence of specific 
secondary metabolites, which are bioactive com-
pounds devoid of undesirable side effects. Mush-
room extracts were reported to have antibacterial, 
hematological, antiviral, antitumor, hypotensive 
and hepatoprotective effects [4, 5]. The fractions 
showing antiviral properties were extracted from 
both mycelia and fruiting bodies. The isolated ac-
tive compounds appeared to play a direct role act-
ing as inhibitors of viral enzymes, synthesis of viral 
nucleic acids or absorption and uptake of viruses 
into mammalian cells. The direct antiviral effects 
were exhibited in particular by small molecules 
and the indirect antiviral effects were the results 
of the activity of polysaccharides or other complex 
molecules [6].
Several triterpenes from Ganodema lucidum 
were reported as active agents against human im-
munodeficiency virus type (HIV-1) [7]. Ganoder-
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at –20 °C and freeze-dried. Dehydrated mate-
rial was homogenized in a mill (JR MF10basic; 
IKA Labortechnik, Staufel, Germany) and sieved 
(Orto Alresa, Madrid, Spain) until particle size 
was smaller than 0.3 mm. Mushroom powder was 
stored at –20 °C for further analysis. Samples were 
prepared in duplicate.
Methanol extracts were prepared by mixing 
the mushroom powders (10 mg) with 250 μl of 
methanol. Suspensions were shaken on a Vortex 
mixer during 2 min and centrifuged (8 854  g for 
2 min). Supernatants were collected and used in 
the assays.
Water extracts were obtained by mixing the 
mushroom powders (10 mg) with 250 μl of Milli-Q 
water (Millipore, Billerica, Massachusetts, USA) 
and treating them as described for methanol ex-
tracts. Resulting aqueous supernatants were im-
mediately used for the antiviral assays or sepa-
rated into a high molecular weight (HMW) or low 
molecular weight (LMW) fractions as described 
later.
Cells and viruses
Vero cells (African green monkey kidney cell 
line) were obtained from the American Type Cul-
ture Collection (ATCC; Rockville, Maryland, 
USA). They were used as host for HSV-1. The 
cells were grown using Eagle’s minimum essen-
tial medium (MEM) supplemented with 5% fetal 
bovine serum (FBS), 1% penicillin-streptomycin, 
1% 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (HEPES) buffer 1 mol·l-1, 1% non- essential 
amino acids and 1% L-glutamine (all from Life 
Technologies, Madrid, Spain). Maintenance 
medium for Vero cells was as described above but 
with 2% FBS.
Herpes virus simplex type 1 (HSV-1; KOS, 
a thymidine kinase-positive and acyclovir-sen-
sitive reference HSV-1 strain, ATCC VR 1493) 
was obtained from ATCC, prepared in aliquots 
and stored at –80 °C until use. Virus titer was de-
termined by plaque reduction assay in Vero cells 
and expressed as plaque forming units (PFU) per 
millilitre. An acyclovir (Sigma, Barcelona, Spain) 
aqueous solution was used as positive control 
against HSV-1 replication.
Cytotoxicity assay
The cytotoxic effect of the different extracts 
on Vero cells was tested using MTT assay, accord-
ing to a published method [20]. The compund 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide (MTT; Sigma) is a yellow water-sol-
uble tetrazolium dye that is reduced by live cells, 
but not by dead cells, to a purple formazan product 
madiol, lucidadiol and applanoxidic acid G, isolat-
ed from G. pfeifferi and other Ganodema strains, 
showed in vitro antiviral activity against influenza 
virus type A. Moreover, ganodermadiol was ac-
tive against HSV-1 [8]. Several neutral or acidic 
protein-bound polysaccharides isolated from wa-
ter extracts of G. lucidum fruiting bodies showed 
inhibitory activities against HSV-1 and HSV-2 [9]. 
In vitro antiviral activity against influenza viruses 
type A and B was demonstrated for two isolated 
phenolic compounds obtained from the fruiting 
body of the basidiomycete Inonotus hispidus [10]. 
Furthermore, water-soluble lignins isolated from 
Inonotus obliquus were also reported to inhibit 
HIV protease [11]. Anti-HIV and anti-human im-
munodeficiency virus activities were described for 
a water-soluble lignin (EP3) presented in the my-
celial culture medium of Lentinus edodes [12, 13]. 
Moreover, sulphated lentinan from L. edodes com-
pletely prevented HIV-induced cytopathic effect 
[14] and, administrated to HIV positive patients 
together with didanosine, was a more efficient im-
munomodulating treatment than the drug by itself 
[15].
The protein-bound polysaccharides PSK and 
PSP from Coriolus versicolor showed also in vitro 
antiviral effect on HIV and cytomegalovirus [16]. 
Velutin, a ribosome-inactivating protein from 
Fammulina velutipes, caused the inhibition of 
HIV-1 reverse transcriptase [17]. Other saccha-
ride-binding proteins, such as lectins from Boletus 
edulis and Pleurotus citrinopileatus, showed high 
antiviral activities. The P. citrinopileatus lectin was 
a homodimeric 32.4 kDa protein able to inhibit 
the HIV-1 reverse transcriptase with the concen-
tration of the substance required to reduce the 
plaque number in Vero cells by 50% (IC50) being 
0.3 μmol·l-1 [18, 19].
The present work studies the antiviral activity 
against herpes virus type 1 of water and metha-
nol extracts, and their polysaccharide fractions, 
obtained from the fruiting bodies of three edible 
mushrooms commonly consumed in European 
countries. The responsible compounds and their 
potential mechanism of action are also postulated.
MATERIALS AND METHODS
Biological material and samples preparation
Mushroom strains used in this investigation 
were Boletus edulis (Fries/Bull.), Lentinus edodes 
(Berkeley) and Pleurotus ostreatus (Imbach). Fresh 
fruit bodies were purchased at a local supermarket 
in Spain.
Mushrooms were cut to small pieces, frozen 
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that is insoluble in aqueous solutions. Monolayers 
of Vero cells in 24-multiwell plates were incubated 
with MEM containing different concentrations 
of the mushroom extracts for 48 h at 37 °C. Cells 
were then washed with phosphate-buffered saline 
(PBS), 0.5 mg·ml-1 of MTT were added to each 
well and incubated 4 h at 37 °C. Supernatants were 
discarded and formazan crystals dissolved in an 
extraction solution (10% sodium dodecyl sulphate 
in a mixture of dimethyl formamide and water 
1 : 1, v/v, adjusted to pH 4.7 with acetic acid) over-
night at 37 °C. Formazan quantification was per-
formed by measuring the optical density at 570 nm 
using a multiscanner autoreader (Sunrise; Tecan, 
Crailsheim, Germany) with the extraction solution 
as a blank. The data were plotted as dose-response 
curves, from which the concentration required to 
reduce the number of viable Vero cells by 50% 
(CC50) after 48 h of incubation with the different 
extracts were obtained.
Evaluation of virucidal activity
Virus samples containing 105 PFU·ml-1 were 
mixed and incubated at 37 °C for 1 h with MEM 
containing different extract concentrations or 
MEM alone (control). Samples were then diluted 
and used to infect confluent Vero cells for 1 h at 
37 °C. After incubation, the virus inocula were 
removed, the cells washed with PBS and then 
overlaid with maintenance medium (with 0.5% 
agarose) for 48 h at 37 °C. The infected cells were 
fixed with acetone : methanol (50 : 50) at 4 °C, 
stained with a 1% solution of crystal violet and the 
number of the plaques counted. The percentage 
of inhibition of plaque formation (IPC) was calcu-
lated as follows:
 (1)
where PC is mean number of plaques in control 
and PT is mean number of plaques in test.
Influence of various treatment periods 
on the anti-HSV-1 activity of the extracts
Vero cells and viruses were incubated with the 
extracts at different stages during the viral infec-
tion cycle in order to determine the mode of anti-
viral action.
1. Cells pre-treatment
Monolayers of Vero cells in 24-multiwell plates 
were pre-treated with MEM containing differ-
ent concentrations of the extracts for 3 h at 37 °C. 
Cells were then washed with PBS and infected 
with 120 PFU of HSV-1. After incubation for 1 h 
at 37 °C, the virus inocula were removed, the cells 
washed with PBS and then overlaid with main-
tenance medium (with 0.5% agarose) for 48 h at 
37 °C. The infected cells were fixed, stained and 
the number of the plaques counted. Control con-
sisted of untreated cells infected with HSV-1.
2. Adsorption period
Cells were infected with 120 PFU of HSV-1 
in presence of different concentrations of the 
extracts for 1 h at 37 °C. Then, the virus inocula 
and the extract were removed, the cells washed 
with PBS and then overlaid with maintenance me-
dium (with 0.5% agarose) for 48 h at 37 °C. The 
infected cells were fixed, stained and the number 
of plaques counted. Control consisted of cells in-
fected without the extract.
3. Intracelullar replication
Cells were infected with 120 PFU of HSV-1. 
After incubation for 1 h at 37 °C, the virus inocula 
were removed, the cells washed with PBS and then 
overlaid with maintenance medium (with 0.5% 
agarose) containing different concentrations of 
the extracts or only medium (control). After in-
cubation for 48 h at 37 °C, the infected cells were 
fixed, stained and the number of plaques counted. 
The concentration of a substance required to 
reduce plaque number in Vero cells by 50% (IC50) 
as compared to control, was calculated from the 
dose-response curves generated from the data.
Isolation of LMW and HMW fractions 
and determination of total phenol and peptides
Mushroom water extracts were submitted to 
filtration using Microcon filters (Millipore) with 
a cut-off value of 10 000 Da and a microcentrifuge 
(8 854  g). The filtrate was considered as LMW 
fraction and the concentrated fraction retained 
in the filter as HMW fraction after mixing of the 
fraction with the same volume of water.
The total phenol concentration was determined 
by the Folin-Ciocalteu method according to the 
procedure of RAMIREZ-ANGUIANO et al. [21]. The 
amount of peptides and polypeptides present in 
LMW aqueous extracts (or proteins in the HMW 
fractions) was determined using a commercial as-
say (Sigma) based on the BRADFORD method [22]. 
Gallic acid and bovine serum albumin BSA were 
used as standards for phenol and protein quantifi-
cation, respectively.
Isolation of polysaccharide fractions
In order to isolate only the polysaccharides 
present in the water extract, mushroom powders 
(1 g) were mixed with sea sand (4 g) and submitted 
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to accelerated solvent extraction (ASE) at room 
temperature during 25 min (5 cycles of 5 min, GIL-
RAMÍREZ, A. et al. [23]). Extracted fractions were 
cooled down to 4 °C and mixed with two volumes 
of cold ethanol under vigorous stirring allowing 
polysaccharides precipitation, and maintained at 
4 °C overnight.
Total polysaccharides present in the mush-
rooms were also isolated according to JEURINK 
et al. [24]. Briefly, the mushroom powders were 
mixed with distilled water at 120 °C (1 g/100 ml) for 
20 min and cooled down to 4 °C. Polysaccharides 
were precipitated by adding two volumes of cold 
ethanol, vigorous stirring, and allowing polysac-
charide precipitation overnight at 4 °C. 
The obtained precipitates (from the water ex-
tracts and from the complete mushroom) were 
collected by centrifugation (10 000 × g for 20 min 
at 4 °C), re-dissolved in distilled water and the 
entire precipitation procedure was repeated. The 
precipitates were dialysed with Spectra/Por 3 mo-
lecular-porous membrane tubing (MWCO: 3500; 
Spectrum Medical Industries, Houston, Texas, 
USA) against distilled water to remove com-
pounds of low molecular weight during at least 
24 h with three or four changes of the distilled wa-
ter. After the dialysis, the polysaccharides remain-
ing in the dialysis tube were collected and freeze-
dried. The freeze-dried polysaccharides were 
weighed and stored at –20 °C until further use.
Determination of total saccharide content
The polysaccharide extracts were analysed for 
their total saccharide content with the modified 
phenol-sulphuric acid method described by FOX 
and ROBYT [25]. Test solutions (25 μl) or standards 
of known glucose concentration with 25 μl of 5% 
(w/v) phenol were added to a microtube. The mi-
crotube contents were stirred in a vortex for 30 s, 
placed on crushed ice, added 125 μl of concen-
trated H2SO4 and heated in a water bath at 80 °C 
for 30 min. Afterwards, absorbance at 490 nm was 
determined (Evolution 600; Thermosceintific, 
Horsham, United Kingdom).
Determination of - and - glucans
The -glucan content of the obtained poly-
saccharides (PSC) extracts (50 mg) was deter-
mined using a -glucan determination kit specific 
for mushrooms and yeasts (Megazyme, Barcelo-
na, Spain) following the instructions of the user's 
manual. Absorbance at 510 nm was measured 
the spectrophotometer. The procedure calculates 
the -glucan content directly from mushroom 
powder by subtracting the values obtained from 
a first assay in which the content of total glucans 
(-glucan + -glucan), D-glucose in oligosaccha-
rides, saccharose and free D-glucose are quan-
tified, to a second assay, in which the content of 
-glucans (glycogen and starch), D-glucose in 
saccharose and free D-glucose are quantified. 
Therefore, if these assays are carried out using the 
HMW fractions obtained after dialysis (polysac-
charide fraction), mono-, di- and oligosaccha-
rides as well as broken or small polysaccharides 
are lacking. Thus, the values obtained with the 
first assay should be due to the total glucans and 
in the second assay to -glucans. Therefore, in 
these types of samples water-insoluble total, - 
and -glucans of a molecular weight higher than 
3.5 kDa can be quantified.
Determination of chitin
Chitin determinations were carried out accord-
ing to VETTER [26] following an adapted method 
of SMITH and GILKERSON [27]. Briefly, PSC ex-
tracts (20 mg) were mixed with 2.5 ml of 6 mol·l-1 
HCl in tubes and incubated in oil bath at 106 °C 
during 24 h. Hydrolysed samples were centrifuged 
at 1 420  g for 60 min. Supernatants (50 μl) were 
brought to a final volume of 200 μl with 6 mol·l-1 
HCl and mixed with 400 μl of 2.5% NaNO2, 
shaken in a vortex and allowed to stand at room 
temperature for 15 min. Afterwards, 12.5% am-
monium sulfamate (200 μl) was added. The mix-
ture was shaken and incubated at room tempera-
ture for 5 min. After the liberation of the excess 
of NaNO2, 0.25% 3-methyl-2-benzothiozolinone 
hydrazine hydrochloride hydrate (MBTH; 200 μl) 
was added, shaken once more and incubated at 
37 °C for 30 min. After incubation, 0.5% FeCl3 
(200 μl) was added and further incubated at 37 °C 
during 5 min. Samples were cooled down to room 
temperature and the absorbance at 650 nm was 
measured by the spectrophotometer.
Statistical analysis 
One way analysis of variance (ANOVA) was 
performed using a Statgraphics Plus 3.1 software 
(Statistical Graphics, Rockville, Maryland, USA). 
Fisher’s least significant differences procedure 
(LSD) was used as the mean comparison test.
RESULTS AND DISCUSION
Cytotoxicity of mushrooms extracts
The water and methanol extracts obtained 
from L. edodes, B. edulis and P. ostreatus were 
initially evaluated for cytotoxicity on pre-formed 
monolayers of Vero cells by MTT method. The 
CC50 data obtained (Tab. 1) indicated that metha-
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nol extracts showed a lower cytotoxicity than the 
water extracts. Among the different mushrooms, 
Lentinus edodes extracts presented the highest 
toxicity.
Virucidal activity of mushroom extracts
In order to investigate the direct inhibitory 
effect of the mushroom extracts against HSV-1, 
a virus suspension was treated at 37 °C for 1 h 
with different concentrations of the extracts. Pre-
incubation of HSV-1 with mushroom extracts re-
sulted in dose-dependent reduction of remaining 
virus infectivity when compared with the untreat-
ed control (Fig. 1). However, the concentrations 
with 50% virucidal activities against the virus 
were higher than 3.75 mg·ml-1 for water extracts 
and 18.75 mg·ml-1 for methanol extracts. These 
results indicated that methanol extracts almost 
lacked extracellular virucidal activity, and wa-
ter extracts provoked only very low direct effects. 
Lentinus edodes water extracts showed higher viru-
cidal effects than the water extracts from the other 
mushrooms. When L. edodes water extracts were 
applied at 3.75 mg·ml-1, they were able to provoke 
50% inhibition, while B. edulis and P. ostreatus ex-
tracts at similar concentrations only reached 25% 
and 15% inhibition, respectively.
Influence of various treatment periods 
on the anti-HSV-1 activity of the extracts
Vero cells were pre-treated for 3 h with dif-
ferent concentrations of the methanol and water 
extracts. Afterwards, extracts were removed, cells 
washed and infected with the HSV-1 virus. Results 
suggested that in cells pre-treated with 75 μg·ml-1 
and 100 μg·ml-1 water extracts, the virus infection 
was inhibited by approx. 60% and 90%, respec-
tively (Fig. 2). However, 100 μg·ml-1 methanol 
extracts reduced the virus infectivity only by 50% 
to 40%. The inhibition rates were similar among 
the three studied mushrooms species. These data 
suggested that mushroom extracts interfered with 
the HSV-1 infection process at the initial infection 
steps perhaps by blocking virus attachment or ad-
sorption to Vero cells.
In order to investigate the influence of ex-
tracts on virus adsorption, cells were infected with 
HSV-1 in presence of different concentrations of 
the extracts for 1 h at 37 °C. Then, the virus inocu-
la and the extract were removed, the cells washed 
with PBS and maintained for 48 h at 37 °C. Ad-
dition of 50 μg·ml-1 and 75 μg·ml-1 water extracts 
reduced the virus infectivity by 60% and 80%, re-
spectively (Fig. 3). In that case, methanol extracts 
were less effective than the water ones.
Tab. 1. Antiviral activities of edible mushroom extracts against herpes simplex virus type 1.
Mushroom Sample CC50 [μg·ml-1] IC50 [μg·ml-1] SI
L. edodes
Water extract 384.15  12.26 a 27.04  1.18 a 14.21
Methanol extract 791.37  21.26 b 96.44  8.26 b 8.2
Polysaccharide fraction 787.83  15.41 b 4.70  0.48 c 167.62
B. edulis
Water extract 490.42  13.78 a 35.12  2.06 a 13.96
Methanol extract 1 142.56  27.45 b 86.17  9.26 b 13.25
Polysaccharide fraction 851.47  17.15 c 5.96  0.61 d 142.86
P. ostreatus
Water extract 404.42  15.36 a 26.69  1.87 a 15.15
Methanol extract 1  004.21  31.04 b 94.24  7.26 b 10.65
Polysaccharide fraction 784.24  13.72 c 4.80  0.39 c 163.38
L. edodes + B. edulis Polysaccharide fraction 834.25  12.58 c 5.90  0.54 d 141.40
L. edodes + P. ostreatus Polysaccharide fraction 792.34  14.58 b 4.53  0.41 c 174.91
B. edulis + P. ostreatus Polysaccharide fraction 798.75  20.14 b 6.02  0.59 d 132.68
L. edodes + B. edulis + P. ostreatus Polysaccharide fraction 801.19  18.58 b 5.74  0.46 d 139.58
Acyclovir Water solution 678.36  14.58 d 0.20  0.03 e 3 391.8
Values are the mean ± standard deviation of three separate experiments.
a, b, c, d, e – denotes statistically significant differences (p < 0.05) between samples extracts from the same mushroom.
CC50 – (cytotoxic concentration 50%) concentration required to reduce 50% the number of viable Vero cells after 48 h incubation 
with the extracts; IC50 – (effective concentration 50%) concentration required to reduce plaque number in Vero cells by 50%. 
Each value is the mean of four determinations standard deviation; SI – selectivity index, ratio CC50/IC50.
Vero cells were infected with HSV-1 (120 PFU) and incubated at 37 °C for 1h. The unabsorbed viruses were removed and the 
cells washed with PBS. The infected cells were further incubated in the presence of different extracts concentrations at 37 °C for 
48 h. The cells were then fixed, stained and the number of plaques counted.
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Fig. 1. Virucidal effect of water and methanol extracts obtained from edible mushrooms against HSV-1.
Each bar is the mean of four determinations ± standard deviation. * – denotes statistically significant differences (p < 0.05) 
between control assays (without extract supplementation) and those carried out in the presence of the extracts.
Fig. 2. Effect of cell pre-treatment with water and methanol extracts from edible mushrooms on HSV-1 infectivity.
Each bar is the mean of four determinations ± standard deviation. * – denotes statistically significant differences (p < 0.05) 
between control assays (without extract supplementation) and those carried out in the presence of the extracts.
Fig. 3. Effect of water extracts and methanol extracts from edible mushrooms during HSV-1 adsorption period. 
Each bar is the mean of four determinations ± standard deviation. * – denotes statistically significant differences (p < 0.05) 
between control assays (without extract supplementation) and those carried out in the presence of the extracts.
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Comparing data obtained during the adsorp-
tion stage with those obtained in the pre-treat-
ment step, when water extracts were applied at 
75 μg·ml-1, at cell pre-treatment the infectivity was 
reduced by 60%, while the same concentration 
added during the adsorption period lead to a 80% 
reduction. These results indicate that mushroom 
water extracts affect mainly the virus adsorption 
step.
The antiviral activity of the extracts on the in-
tracellular replication of the virus was evaluated 
by adding different concentrations of the mush-
room extracts to previously HSV-1 infected Vero 
cells, and incubation for 48 h at 37 °C. Both wa-
ter and methanol mushroom extracts showed 
a dose- dependent inhibition of virus replication. 
The water extracts were more efficient against 
HSV-1 replication than the methanol extracts, 
showing IC50 values ranging from 26.69 μg·ml-1 to 
35.12 μg·ml-1 (Tab. 1). P. ostreatus and L. edodes 
water extracts showed a potent inhibition effect 
against HSV-1 replication with the lowest IC50 
values of the studied species. Comparing these 
data with those obtained during the adsorption 
period, for the same water extract concentration 
(25 μg·ml-1), it can be seen that this concentration 
reduced the virus infectivity by 20% when added 
during adsorption period, and by 50% when added 
after virus infection. Thus, mushroom extracts 
mainly inhibited HSV-1 intracellular replication, 
although they were also able to disrupt the virus 
adsorption step. Other mushroom strains, such as 
Gano derma lucidum, showed higher IC50 values 
(300 μg·ml-1) indicating that the species might be 
an interesting source of antiviral compounds [28].
The antiviral activities of edible mushrooms 
have been usually ascribed to the effects of water 
extracts and frequently related to the presence of 
water-soluble polysaccharides. ZHANG et al. [29] 
reported the antiviral activity against HSV-1 of 
-glucans isolated from the sclerotium of Pleuro-
tus tuber-regium and KIM et al. [30] reported the 
antiherpetic activity of the acidic protein-bound 
polysaccharide isolated from water-soluble ex-
tracts from G. Lucidum fruiting bodies. Also, 
sulphates of a -(13)-D-glucan from Lenti-
nus edodes (lentinan) was reported to possess 
a considerable anti-HSV-1 activity [14]. However, 
other type of compounds have also been identi-
fied as responsible for the antiviral activities. For 
instance, two phenolic compounds were isolated 
from Ino notus hispidus fruiting bodies with a re-
markable activity against influenza viruses type 
A and B [10], a peptide with HIV-1 reverse tran-
scriptase inhibitory activity was isolated from 
Russula paludosa [31] and three triterpenes from 
Ganoderma pfeifferi were active against influenza 
virus type A and HSV-1 [8]. Therefore, in order to 
better define the antiherpetic compounds in the 
mushroom strains selected in this study, two dif-
ferent fractions were separated, LMW and HMW 
fractions. The latter was further treated to isolate 
the PSC present in water extracts. 
Antiviral activity of LMW fractions
Since triterpenes are not extracted with water 
and the obtained methanol extracts showed lower 
antiviral activity, the high activity found in water 
extracts cannot be due to compounds of this type. 
The LMW fraction contained mainly phenolic 
compounds and peptides, the contents of pheno-
lics being higher than that of peptides. L. edodes 
was the mushroom with the highest phenolic con-
tent (Tab. 2). The antiviral activity of these frac-
tions was measured under the same conditions as 
previously described for water extracts. Neverthe-
less, these fractions were not able to significantly 
reduce the virus infectivity at any of the previously 
described stages of the HSV-1 viral infection cycle 
(pre-treatment period, adsorption stage or replica-
tion period) suggesting that antiviral compounds 
of B. edulis, L. edodes and P. ostreatus water ex-
tracts were HMW molecules.
Antiviral activity of HMW fractions
The HMW fraction of the water extracts con-
tained many proteins and a few easily extractable 
polysaccharides. P. ostreatus was the mushroom 
Tab. 2. Composition of LMW and HMW fractions of the mushroom water extracts.
Water extracts
LMW compounds HMW compounds
Phenols [%] Peptides [%] Proteins [%] PSC [%]
Lentinus edodes 33.15  0.92 a 3.33  0.11 b 27.40 1.20 a 7.54 4.32 b
Boletus edulis 18.96  0.08 a 2.21  0.22 b 31.45 2.01 a 7.57 0.81 b
Pleurotus ostreatus 11.36  1.24 a 3.00  0.34 b 43.46 5.64 a 12.91 3.10 b
Values are the mean ± standard deviation of two separate experiments.
LMW – low molecular weight, HMW – high molecular weight. a, b – denotes statistically significant differences (p < 0.05) 
between peptides and phenolic content or proteins and polysaccharides.
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with the highest content of both proteins and 
polysaccharides (Tab. 2). Since many publications 
identified fungal polysaccharides, saccharides-
binding proteins or proteoglucans as responsible 
for the antiviral activities in other mushrooms or 
for other viruses, a more detailed analysis of the 
polysaccharide fraction (including possible proteo-
glucans) was carried out. Results indicated that the 
polysaccharides easily extractable at room tem-
perature were mainly -glucans followed by chitins 
in P. ostreatus and L. edodes mushrooms, while 
B. edulis contained more chitins, determined as 
glycosaminoglucan hexosamine (Tab. 3). Water ex-
tracts from the latter strain were also the extracts 
that showed lower antiviral activity compared with 
the other two strains (Tab. 1). However, IC50 of 
35.1 μg·ml-1 suggested a rather interesting antiviral 
activity considering that only 2.8 g·kg-1 -glucan 
were detected and so other compounds, such as 
proteins, might be involved in the antiviral activi-
ties observed.
Antiviral activity of polysaccharides extracts
In order to further clarify whether the antiviral 
compounds were polysaccharides or proteins, the 
mushroom polysaccharides were isolated and their 
cytotoxicities and antiherpetic activities measured 
under the same conditions as previously described 
for water extracts, except for virucidal effects. This 
activity was not measured in the polysaccharide 
fractions since water extracts presented a very low 
virucidal activity. Moreover, if the fungal -glucans 
were the antiviral compounds, the real antiviral 
activity might be underestimated since plain wa-
ter extraction is not the best method to extract 
them. Therefore, the antiviral activities of these 
new fractions were compared with those obtained 
by the water extraction. The cytotoxicity assays of 
these polysaccharide fractions (Tab. 1) indicated 
a lower toxicity values than the water extracts. 
Among the different mushrooms, Boletus edulis 
extracts presented the lowest toxicity.
When Vero cells were pretreated with 
50 μg·ml-1 of the polysaccharide fractions, virus in-
fection was inhibited by approx. 50% in all cases 
(Fig. 4A). However, when the water extracts were 
applied at this concentration, only 10% inhibi-
tion was observed. Moreover, if 50 μg·ml-1 of the 
polysaccharide fractions were applied during the 
virus adsorption period, the infectivity was re-
duced by 60–65% (Fig. 4B), while a reduction of 
40% was observed when water extracts were used. 
Since these fractions contained 10- to 15-fold 
more polysaccharides than the water extracts 
(Tab. 3), polysaccharides could be identified as the 
compounds responsible for the antiviral activity of 
the water extracts of the mushrooms.
The antiviral activity of the polysaccharide 
fractions on the intracellular replication of the vi-
rus was also evaluated, showing IC50 values rang-
ing from 4.70 μg·ml-1 to 5.96 μg·ml-1 (Tab. 1). 
Worth to mention is the fact that these enriched 
extracts presented a very high selectivity indexes, 
identifying them as an interesting source of antivi-
ral compounds.
When the different polysaccharides present in 
the extracts were individually measured (Tab. 3), 
the -glucans represented the highest percent-
age of polysaccharides in P. ostreatus and L. edo-
des extracts, while B. edulis contained the levels of 
chitins higher than the levels of other -glucans. 
These results pointed to -glucans as the com-
pounds responsible for the antiviral activity of 
P. ostreatus and L. edodes extracts in agreement 
with previous reports mentioning sulphated 
-glucans as responsible for the antiviral activity 
against other viruses in in vitro and in vivo studies 
[14, 15, 29]. However, also other compounds 
Tab. 3. Polysaccharides contents in the water extracts and in the polysaccharides extracts 
isolated from the mushrooms.
PSC in the water extracts Total [g·kg-1] -glucans [g·kg-1] -glucans [g·kg-1] Chitins [g·kg-1]
Lentinus edodes 15.131.24 a 13.251.70 a 1.340.29 a 9.220.85 a
Boletus edulis 15.683.00 a 2.790.02 b 0.200.01 b 12.460.78 b
Pleurotus ostreatus 19.884.39 a 13.890.12 a 0.490.15 c 11.552.22 b
PSC extracts from mushrooms
Lentinus edodes 189.2227.50 a 186.5031.57 a 12.357.45 a 44.358.56 a
Boletus edulis 243.1217.10 b 64.460.60 b 25.261.59 b 118.7110.93 b
Pleurotus ostreatus 209.6158.74 b 196.9557.96 a 38.0612.34 b 30.1417.60 a
Contents are expressed in grams per kilogram of mushroom powder dry weight. Values are the mean ± standard deviation of 
two separate experiments.
PSC – polysaccharides; a, b, c – dtenotes statistically significant differences (p < 0.05) between the three mushroom species.
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might be involved in the antiviral activities found 
in B. edulis as, although this mushroom showed an 
IC50 higher than the other two species, values of 
5.9 μg·ml-1 indicate an interesting antiviral activity. 
Perhaps in this case, the lectins described in this 
mushroom might be chitin-binding lectins, due to 
the high chitin levels found, and might be respon-
sible for the observed activity [18, 32] since fungal 
chitins lacked antiviral activities by themselves. 
Nevertheless, all the PSC fractions were able to in-
hibit the virus adsorption step, but they mainly in-
hibited the HSV-1 infection by interfering with the 
intracellular virus replication. Similar results were 
previously described for other mushroom strains, 
such as Agaricus brasiliensis. The antiviral polysac-
charides isolated from this mushroom were able to 
inhibit the initial stage of the virus replication [33].
In order to investigate if the combination 
of the polysaccharide fractions from the three 
mushrooms exhibited synergistic effects, the ex-
Fig. 4. Effect of cell pre-treatment with polysaccharide-rich fractions from edible mushrooms 
on HSV-1 infectivity and during HSV-1 adsorption period.
A – Effect on HSV-1 infectivity. B – Effect during HSV-1 adsorption period.
Each bar is the mean of four determinations ± standard deviation. * – denotes statistically significant differences (p < 0.05) 
between control assays (without polysaccharide supplementation) and those carried out in the presence of the polysaccharide 
fractions.
Fig. 5. Effect of cell pre-treatment with combination of polysaccharide-rich fractions 
on HSV-1 infectivity and during HSV-1 adsorption period. 
A – Effect of on HSV-1 infectivity. B – Effect during HSV-1 adsorption period.
Polysaccharide-rich fractions were applied in pairs or all three fractions together. Each bar is the mean of four determinations ± 
standard deviation. * – denotes statistically significant differences (p < 0.05) between control assays (without polysaccharide 
supplementation) and those carried out in the presence of the polysaccharide fractions.
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tracts were mixed in a ratio of 1 : 1 (v/v) in pairs 
and also pooled all together in a ratio of 1 : 1 : 1 
(v/v/v). The antiviral activity of these mixtures was 
measured under the same conditions as previously 
described for the individual polysaccharide frac-
tions. The polysaccharide combinations showed 
values of virus infectivity at any of the stages of the 
HSV-1 viral infection cycle (pre-treatment period, 
adsorption stage or replication period) that were 
similar to those determined with each individual 
polysaccharide fraction (Fig. 5, Tab. 1). No synergy 
effects were detected within the polysaccharides of 
the three mushrooms.
CONCLUSION
Concluding, the PSC fractions obtained from 
L. edodes, B. edulis and P. ostreatus might be 
a novel source of compounds able to prevent 
HSV-1 infections, since 50 μg·ml-1 of their polysac-
charide extracts applied as a pre-treatment in-
hibited the virus infectivity by approx. 50% and, 
applied during the virus adsorption period, the 
infectivity was reduced by 60-65%. These results 
could be of interest since the antiviral studies are 
normally focused on treating the viral infection but 
not on preventing it. Furthermore, these polysac-
charide extracts showed also a high inhibitory ac-
tivity against the intracellular virus replication, 
therefore they might be used as a treatment after 
the virus infection. In order to investigate these 
interesting possibilities, animal studies should be 
carried out before clinical trials with mushroom 
polysaccharides can be planned.
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